Autoimmunologiczna niedokrwistość hemolityczna: badanie fazy III leku rilzabrutinib
A Study to Investigate the Efficacy, Safety, and Pharmacokinetics of Oral Rilzabrutinib Compared With Placebo in Participants 18 Years of Age and Older With Warm Autoimmune…